Our Story

It’s about helping people survive fatal bleeding injuries.

Our vision is to replace the conventional ways of wound management with our biomaterial-based solutions & making them available to the masses especially to those who are underprivileged.

“You cannot connect the dots looking forward,
you can only connect them looking backwards”.
                                            ­­­______ Steve Jobs

Tracing back to each incident of my life, it seemed Miraqules was destined for me. It all started when my father had an accident. The bleeding could have killed him as it could not be controlled with my clothes or gauze or whatever was available at that point. Thanks to God – with timely medical intervention my father survived, but that horrible incident left me with a fear of the total nothingness of death.

 

I believe it was destiny that two years later, I was at NIT Rourkela working under Dr. Devendra Verma on biomaterial-based hemostats. Under his guidance, I developed a novel, cost-effective manual process to produce porous & fibrous compounds that mimic human blood clotting protein – fibrin. These compounds were found to be almost 10 times more effective in causing hemostasis than our body’s own blood clotting mechanism and almost 5 times faster than the existing commercial blood clotting agents.

 

The need for hemostats was obvious to me but Miraqules took off when Mubeen shared his experience of witnessing seven people bleed to death on a single night. He trusted and envisioned the invention, and decided to venture along with me. He resigned from his surgeon’s position at a reputed hospital & joined hands with me in building Miraqules. Certainly, the invention was no longer confined to the lab. Today, Miraqules’ StopBleed has advanced into clinical trials and the company is backed by national & international organizations. We are guided and advised by renowned biomedical engineers & doctors. To date, Miraqules has raised around INR 1.6 crores ($210K) as non-dilutive and INR 3 crores ($400K) as dilutive funding. Miraqules is set on a path to revolutionize the industry with its scalable wound management technology platform, and more importantly saving lives from severe bleeding. The ulterior motive is to address all the gaps in wound management with our novel, cost-effective hemostatic products.

 

                                                                                                                                              ——Sabir Hossain, Founder and CEO, Miraqules

Our Journey
2018

Q2-2018 – Established initial proof of concept.

Q3-2018 – First patent filed.

Q4-2018 – Received grant from Government of India.

2019

Q2-2019 – Prototyping completed & Second patent filed.

Q4-2019 – PCT applications made for both the patents.

2020

Q2-2020 – Preclinical trail completed & Functioning prototype released.

Q3-2020 – Received post approval field trails opportunity from Indian & Israeli Defense force.

Q4-2020 – Received test License from Indian regulatory authority CDSCO for Large animal trial.

2021

Q1-2021 – US FDA Pre-submission.

Q2-2021 – Production process scale-up completed.

Q4-2021 – Submission of the Q-Sub.

2022

Q1-2022 – Received response on the Q-Sub.

Q2-2022 – Pilot scale manufacturing.

2023

Q4-2023 – US FDA approval (Expected).

Our Achievement

$400K

Pre-seed Round 2021

$10K

Top 4 Finalists 2021

$10k

TOP 20 Global start-ups to win 2020

TOP 100 global start-ups 2020

Birla Global Innovation Challenge
INR 5 Lakhs

Winner 2020

INR 25 Lakhs

GOI investment 2020

INR 15 Lakhs

Grant 2020

ILS 100K

Winner 2019

INR 10 Lakhs

Winner 2019

world’s top 500 deep tech startups

INR 50 Lakhs

Grant 2018

INR 6 Lakhs

Grant 2018

Our Achievement

1. Received pre-seed investment from a Silicon Valley based investor – INR 3 Crores ($400K)
2. Selected as one of the Top 4 Finalists for the MedTech Innovator Asia Pacific Accelerator program 2021- $10K
3. One of the TOP 20 Global start-ups to win Y Combinator sprint grant 2020 – $10k.
4. Considered as one of the TOP 100 global start-ups by Slingshot, Singapore Government.
5. Honoured to get invited to be a speaker at IISF,2020 organised by NSTEDB, DST, India
6. Winner of Birla Global Innovation Challenge2020 – INR 5 Lakhs
7. Received Seed fund from Government of India 2020 – INR 25 Lakhs
8. Received Grant from State Government of Odisha, India 2020 – INR 15 Lakhs
9. Won the MassChallenge Platinum Winner Title’2019 – ILS 100K
10. Won the Dare to Dream contest organized by Defense Research and Development Organization, India2019 –INR 10 Lakhs
11. Represented state of Odisha at the Global BioAsia Conclave 2019
12. Represented state of Odisha at the Global BioIndia Conclave 2019
13. Counted at world’s top 500 deep tech startups by Hello Tomorrow 2018
14. Received BIG Grant from Government of India 2018 – INR 50 Lakhs
15. Received NIDHI-PRAYAS Grant from Government of India 2018 – INR 6 Lakhs
16. Own contribution – INR 10 Lakhs
17. Counted as top finalists for RebelBio program, Imperial College London, White City Incubator, UK 2018

Awards & Recognitions

Content will come shortly….